The UCLA Brain Tumor Imaging Laboratory (BTIL) is at the forefront of pioneering advancements in medical imaging, with a central mission to develop, rigorously test, and seamlessly implement cutting-edge MRI and PET imaging biomarkers. These biomarkers show great promise in providing comprehensive insights into the intricate landscape of brain tumor biology and critically evaluating treatment efficacy during clinical trials.
Our dedicated team of accomplished researchers, clinicians, and technologists, collaborates synergistically, to unravel the complexities of brain tumors. With a firm commitment to advancing patient care, BTIL strives to address pressing challenges in brain tumor diagnostics and therapeutics through innovative imaging methodologies.
As an integral part of the Center for Computer Vision and Imaging Biomarkers and a proud member of the UCLA Brain Tumor Program, our lab operates with a vision firmly grounded in scientific excellence. Our aim is to foster transformative breakthroughs that will have a profound impact on patient outcomes and elevate the standard of care for individuals with brain tumors. We envision a future where medical imaging plays a pivotal role in enhancing our understanding of brain tumor biology, leading to more effective treatments and improved quality of life for patients and their families.
Our mission is to lead pioneering research in medical imaging, focusing on the development, validation, and seamless integration of state-of-the-art MRI and PET imaging biomarkers. We are dedicated to unraveling the intricate biology of brain tumors, and through collaborative efforts, we strive to advance patient care and contribute meaningfully to the field of brain tumor diagnostics and therapeutics.
Our vision is to redefine the landscape of brain tumor research through cutting-edge medical imaging methodologies. By harnessing the power of advanced MRI and PET imaging biomarkers, we envision a future where precision diagnostics and treatment evaluations become integral components of brain tumor management. With a commitment to scientific excellence and compassionate patient-centricity, we aim to improve outcomes and enhance the quality of life for individuals impacted by brain tumors, leaving an indelible mark on the advancement of medical knowledge and patient care.